BlackRock Group’s Omega Protein OME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$167K Sell
6,654
-6,883
-51% -$163K ﹤0.01% 2710
2016
Q3
$316K Buy
13,537
+378
+3% +$8.88K ﹤0.01% 2475
2016
Q2
$263K Sell
13,159
-2,722
-17% -$50.8K ﹤0.01% 2478
2016
Q1
$268K Buy
15,881
+8,037
+102% +$165K ﹤0.01% 2476
2015
Q4
$174K Buy
+7,844
New +$163K ﹤0.01% 2554
2015
Q3
Sell
-19,574
Closed -$269K 3117
2015
Q2
$269K Sell
19,574
-2,045
-9% -$27.2K ﹤0.01% 2488
2015
Q1
$296K Hold
21,619
﹤0.01% 2363
2014
Q4
$229K Hold
21,619
﹤0.01% 2488
2014
Q3
$270K Buy
+21,619
New +$301K ﹤0.01% 2370
2013
Q4
Sell
-63,278
Closed -$644K 2855
2013
Q3
$644K Buy
+63,278
New +$592K ﹤0.01% 2123

Other funds holding OME

BlackRock Group's OME Position: Q4 2016 in Review

BlackRock Group reduced its Omega Protein (OME) stake by 51% in Q4 2016, selling an estimated $163K and leaving 6,654 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #2710.

BlackRock Group first reported a position in OME in Q3 2013 and has held it in 10 quarters since. The position peaked at $644K in Q3 2013. 142 funds tracked by Wall St. Rank hold OME as of Q4 2016.

  • BlackRock Group held 6,654 shares of Omega Protein worth $167K as of Q4 2016.
  • BlackRock Group sold 6,883 Omega Protein shares in Q4 2016, an estimated $163K.
  • Omega Protein made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2710 holding.
  • BlackRock Group first reported a position in Omega Protein in Q3 2013 and has held it in 10 quarters since.
  • BlackRock Group's Omega Protein position peaked at $644K in Q3 2013.
  • 142 funds tracked by Wall St. Rank held Omega Protein as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.